MENU
+Compare
ONC
Stock ticker: NASDAQ
AS OF
Jan 14, 04:59 PM (EDT)
Price
$201.04
Change
+$16.43 (+8.90%)
Capitalization
21.53B

ONC BeiGene Ltd Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

Industry Biotechnology
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ONC with price predictions
Jan 08, 2025

ONC's RSI Indicator ascending out of oversold territory

The RSI Indicator for ONC moved out of oversold territory on December 17, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In of the 30 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on January 08, 2025. You may want to consider a long position or call options on ONC as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ONC just turned positive on December 27, 2024. Looking at past instances where ONC's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONC advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ONC entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.234) is normal, around the industry mean (15.212). P/E Ratio (0.000) is within average values for comparable stocks, (87.972). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.839). ONC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (6.337) is also within normal values, averaging (258.672).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ONC is expected to report earnings to rise 874.67% to -87 cents per share on March 26

BeiGene Ltd ONC Stock Earnings Reports
Q4'24
Est.
$-0.88
Q3'24
Beat
by $0.95
The last earnings report on November 12 showed earnings per share of -9 cents, beating the estimate of -103 cents. With 734.66K shares outstanding, the current market capitalization sits at 21.53B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMP13.320.25
+1.91%
Compass Minerals International
LXP8.030.15
+1.90%
LXP Industrial Trust
TSE4.420.08
+1.84%
Trinseo PLC
UHS184.16-1.58
-0.85%
Universal Health Services
EFSH0.24N/A
-1.20%
1847 Holdings LLC

ONC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+8.87%
ZLAB - ONC
43%
Loosely correlated
-3.65%
MDGL - ONC
42%
Loosely correlated
-9.74%
DNLI - ONC
38%
Loosely correlated
-4.34%
WXXWY - ONC
37%
Loosely correlated
+0.13%
AXON - ONC
37%
Loosely correlated
+1.96%
More